On December 10, 2024, Mark Parrish, a Director at Omnicell Inc (OMCL, Financial), sold 12,000 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns 58,427 shares of the company.
Omnicell Inc (OMCL) is a company that provides medication management solutions and adherence tools for healthcare systems and pharmacies. The company offers a comprehensive suite of products and services designed to improve patient safety, streamline workflows, and reduce costs.
The insider transaction history for Omnicell Inc shows that there have been no insider buys in total over the past year. Meanwhile, there has been one insider sell over the same timeframe, which was conducted by Mark Parrish.
Shares of Omnicell Inc were trading for $47.3 apiece on the day of Mark Parrish’s recent sale. This gives the stock a market cap of $2,128.720 million. With a price of $47.3 and a GuruFocus Value of $48.45, Omnicell Inc has a price-to-GF-Value ratio of 0.98. This means the stock is considered fairly valued based on its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus that is calculated based on the following three factors:
- Historical multiples (price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow) that the stock has traded at.
- A GuruFocus adjustment factor based on the company’s past returns and growth.
- Future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
